文献速递乳腺癌支持与姑息治疗

有氧与抗阻运动干预对早期乳腺癌女性心血管疾病风险的影响:一项随机临床试验

Effect of Aerobic and Resistance Exercise Intervention on Cardiovascular Disease Risk in Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
PubMed 文献 · JAMA Oncol · 2019-01-01

这项单中心前瞻性随机临床试验纳入100例I至III期、超重或肥胖且久坐的乳腺癌女性,随机分为运动组(50例)和常规护理组(50例)。16周监督下有氧与抗阻运动干预后,运动组Framingham风险评分(FRS)较常规护理组显著降低,平均差为-9.5(95%CI -13.0至-6.0),对应FRS预测的10年心血管疾病风险降低11%(95%CI -15.0至-5.0)。

要点

  • 16周监督下有氧与抗阻运动使早期乳腺癌超重/肥胖女性FRS平均降低9.5分(95%CI -13.0至-6.0)。
  • 运动组干预后FRS预测的10年心血管疾病风险降低11%(95%CI -15.0至-5.0)。
  • 干预后运动组平均FRS为2.0(1.5),常规护理组为13.0(3.0)。

核心结论

  • 16周监督下有氧与抗阻运动干预似乎可降低早期乳腺癌超重或肥胖女性FRS预测的10年心血管疾病风险。

研究设计与样本

  • 单中心、前瞻性随机临床试验,纳入100例I至III期乳腺癌女性,随机分为运动组(n=50)和常规护理组(n=50)。
  • 纳入条件为久坐、超重或肥胖(体重指数≥25.0或体脂≥30%),且在入组前6个月内完成癌症治疗。
  • 运动组接受每周3次、共16周的监督下有氧与抗阻运动;采用混合模型重复测量分析,按意向性治疗原则分析。
  • 数据收集时间为2012年8月1日至2017年7月1日,数据分析时间为2018年5月24日至10月2日。

主要发现

  • 干预后运动组平均FRS为2.0(1.5),常规护理组为13.0(3.0)。
  • 运动组干预后FRS较常规护理组显著降低,平均差为-9.5(95%CI -13.0至-6.0)。
  • 运动组FRS预测的10年心血管疾病风险降低11%(95%CI -15.0至-5.0)。
  • 100例女性中55例(55%)为西班牙裔白人,平均(SD)年龄为53.5(10.4)岁。

关键数值与推荐

  • FRS根据6个类别预设分值计算:年龄、收缩压、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、糖尿病存在情况、吸烟状态。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The Framingham Risk Score (FRS) is a valid method for predicting the 10-year risk of developing cardiovascular disease. Higher FRS is reported in patients with early-stage breast cancer who are overweight than in healthy, age-matched women, but whether exercise reduces FRS in this patient population is unclear. OBJECTIVE: To examine the effects of a 16-week aerobic and resistance exercise intervention on the FRS in women with early-stage breast cancer and with overweight condition or obesity. DESIGN, SETTING, AND PARTICIPANTS: This single-center, prospective randomized clinical trial included 100 women with stage I to III breast cancer who were sedentary, with overweight condition or obesity (body mass index of ≥25.0 or body fat of ≥30%), and completed cancer treatment within 6 months prior to enrollment. Participants were randomized to either the usual care or exercise group. Differences in mean changes for outcomes were evaluated using mixed-model repeated-measures analyses. Data were collected from August 1, 2012, through July 1, 2017. Data analysis, which followed the intention-to-treat approach, was performed from May 24 to October 2, 2018. INTERVENTIONS: The exercise group underwent supervised aerobic and resistance exercise sessions thrice weekly for 16 weeks. MAIN OUTCOMES AND MEASURES: The FRS was calculated for each participant using preset points for each of the 6 FRS categories: age, systolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, diabetes presence, and smoking status. RESULTS: In total, 100 women were randomized to either the exercise group (n = 50) or usual care group (n = 50). Of these women, 55 (55%) were of Hispanic white race/ethnicity and the mean (SD) age was 53.5 (10.4) years. The mean (SD) total FRS scores postintervention were 2.0 (1.5) in the exercise group and 13.0 (3.0) in the usual care group. The postintervention FRS was significantly reduced in the exercise group compared with the usual care group (mean, -9.5; 95% CI, -13.0 to -6.0), which corresponds to an 11% (95% CI, -15.0 to -5.0) decrease on the FRS-predicted 10-year risk of developing cardiovascular disease. CONCLUSIONS AND RELEVANCE: A 16-week supervised aerobic and resistance exercise intervention appeared to reduce the FRS-predicted 10-year risk of cardiovascular disease in women with early-stage breast cancer with overweight condition or obesity. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01140282.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Lee K, Tripathy D, Demark-Wahnefried W, et al. Effect of Aerobic and Resistance Exercise Intervention on Cardiovascular Disease Risk in Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. 2019. PMID: 30920602. doi:10.1001/jamaoncol.2019.0038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。